MKI67 and neoplasm: Based on our collective results and those published in the literature,26, 58, 92–96 we developed a new score that integrates patient- and tumour-specific characteristics (age ⩾60 years, performance status, lactate dehydrogenase, and Ki-67 marking >80%) and identifies three clear-cut groups of patients with different prognosis.